You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Laboratory Corporation of America has completed its previously announced $1.2 billion cash acquisition of contract research organization Chiltern, which will become part of the company's Covance drug development business.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.